Letter: Double-blind trial for treatment of herpes iritis and stromal disease.
D000225:Adenine / Q000627:therapeutic use; D000998:Antiviral Agents / Q000627:therapeutic use*; D001089:Arabinose / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D006566:Herpesviridae Infections / Q000188:drug therapy*; D006801:Humans; D007500:Iritis / Q000188:drug therapy*; D007635:Keratitis, Dendritic / Q000188:drug therapy*; D009705:Nucleosides / Q000627:therapeutic use*
D000998:Antiviral Agents; D009705:Nucleosides; D001089:Arabinose; D000225:Adenine